Focus Groups

Enhancing Transparency and Compliance in Healthcare Supply Chains: The Role of UDI and Proactive Identification and Tracking

This focus group will discuss critical challenges in healthcare supply chains caused by rising tariffs and increasing demands for transparency. Participants will explore how the Unique Device Identification (UDI) standard, country of origin identification, combined with proactive lot and serial tracking, can be leveraged to improve product identification and enhance data transparency. By aligning these strategies, the group will work to develop actionable solutions that help customers mitigate costs, prevent fraud related to product origins, and uphold supply chain integrity while continuing to prioritize patient care.

Optimizing Patient Charging Processes: Collaboration, Integration, and Automation

This focus group will explore the complexities of managing the patient charging process in healthcare facilities, with a focus on the collaboration between Supply Chain and Revenue Cycle teams to support the chargemaster. Participants will examine key operational business processes, the integration between ERP and EMR systems, required data, and clinical data standards. The discussion will also highlight opportunities for automating workflows to enhance efficiency, accuracy, and alignment across departments.

Choose the Right Data Coach: Strategies for Hospital Financial Wins

Championship teams don’t wing it. They follow a plan, review performance, and hire coaches. Hospitals should too. This session explores how a data driven coach can reveal hidden savings, reduce leakage, and improve compliance across purchased services, supply chain, and finance. Stop guessing and start seeing measurable financial results.

Intelligent Pharmacy Procurement Software: Driving Better Results Through Automation

Manual procurement slowing you down? Discover how automation improves accuracy, compliance, and savings in your pharmacy. Explore strategies including NDC standardization, supplier selection, 340B compliance, cost transfers, actionable analytics, and decision support. Gain real-world insights and proven solutions from pharmacy experts at Trulla and SpendMend to optimize operations.

The Future of Acute Pain Management: Health System Perspectives on a Treatment for Moderate-to-severe Acute Pain

Vertex Pharmaceuticals received U.S. Food and Drug Administration (FDA) approval in January 2025 for a medication for the treatment of moderate-to-severe acute pain in adults. This marks a significant milestone as it represents the first class of therapy approved for patients with moderate-to-severe acute pain in over 20 years. Join us to share experiences evaluating and adopting this therapy into health systems across the country. Anticipated topics include insights into clinical decision-making, integration, and the evolving standard of care in acute pain management.